Glucagon
Brand name: Gvoke Hypopen 2-Pack
Rank #457 of 500 drugs by total cost
$16.6M
Total Cost
31,523
Total Claims
$16.6M
Total Cost
1,533
Prescribers
$526
Cost per Claim
13,717
Beneficiaries
33,591
30-Day Fills
$11K
Avg Cost/Provider
21
Avg Claims/Provider
About Glucagon
Glucagon (sold as Gvoke Hypopen 2-Pack) was prescribed 31,523 times by 1,533 Medicare Part D providers in 2023, costing the program $16.6M. At $526 per claim, this is a high-cost medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 454 | Nitroglycerin (Nitroglycerin) | $16.8M | 768,384 |
| 455 | Lanreotide Acetate (Somatuline Depot) | $16.7M | 1,753 |
| 456 | Clonidine (Clonidine) | $16.7M | 112,710 |
| 457 | Glucagon (Gvoke Hypopen 2-Pack) | $16.6M | 31,523 |
| 458 | Bosentan (Bosentan) | $16.5M | 2,765 |
| 459 | Telmisartan (Telmisartan) | $16.4M | 334,601 |
| 460 | Letermovir (Prevymis) | $16.1M | 2,144 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology